Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,913 DKK | -5.52% | -6.37% | -11.32% |
May. 21 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
May. 21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.32% | 18.96B | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.46% | 21.58B | |
-40.50% | 16.96B | |
-13.41% | 16.33B | |
+6.64% | 14.14B | |
+31.84% | 12.02B | |
-1.82% | 7.58B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment